Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_4101_Библиотеки_им_академика_М_И_Перельмана
.pdf
141
Immunologiae et Therapiae Experimentalis, 2020; 68(4), 1-13.
doi.org/10.1007/s00005-020-00585-3
38. Caliskan E., De Souza D.R., Böning A., Liakopoulos O.J., Choi Y.H., Pepper J.,
Emmert M.Y. Saphenous vein grafts in contemporary coronary artery bypass graft
surgery. Nat. Rev. Cardiol. 2020; 17 (3): 155–69. doi: 10.1038/s41569-019-0249-3
39. Carr B. D., Johnson T. J., Gomez-Rexrode A., Mohammed A., Coughlin M.,
Toomasian J. M. et al. Inflammatory effects of blood-air interface in a porcine
cardiopulmonary bypass model. ASAIO journal (American Society for Artificial
Internal Organs: 1992), 2020; 66(1), 72.
doi.org/10.1097%2FMAT.0000000000000938
40. Chandrashekara S. C‐reactive protein: An inflammatory marker with specific role in
physiology, pathology, and diagnosis. Internet Journal of Rheumatology and Clinical
Immunology, 2014; 2(S1), 105–121. doi.org/10.15305/ijrci/v2iS1/117
41. Chen X., Jiang M., Li H., Wang Y., Shen H., Li X., Chen G. CX3CL1/CX3CR1 axis
attenuates early brain injury via promoting the delivery of exosomal microRNA-124
from neuron to microglia after subarachnoid hemorrhage. Journal of
Neuroinflammation, 2020; 17, 1-15. doi.org/10.1186/s12974-020-01882-6
42. Collaboration F. S. Plasma fibrinogen level and the risk of major cardiovascular
diseases and nonvascular mortality: an individual participant meta-analysis. Jama,
2005; 294(14), 1799-1809. doi:10.1001/jama.294.14.1799
43. Cristian G., Vintila A.M., Ionita-Radu F., Hantulie I., Ioan A.M. Mechanisms of
venous graft failure. In: Coronary graft failure. Springer, Cham. 2016; 267–76. doi:
10.1007/978-3-319-26515-5_24
44. De Rosa S., Cirillo P., Pacileo M., Petrillo G., D'Ascoli L., Maresca F. Neopterin:
from forgotten biomarker to leading actor in cardiovascular pathophysiology. Current
vascular pharmacology, 2011; 9(2), 188-199. doi.org/10.2174/157016111794519372
45. De Rosa R., Vasa‐Nicotera M., Leistner D.M., Reis S.M., Thome C.E., Boeckel J. et
al. Coronary atherosclerotic plaque characteristics and cardiovascular risk factors—
Insights from an optical coherence tomography study. Circulation Journal, 2017; 81,
1165–1173 doi.org/10.1253/circj. CJ-17-0054
142
46. De Vries M. R., Simons K. H., Jukema J. W., Braun J., Quax, P. H. Vein graft
failure: from pathophysiology to clinical outcomes. Nature Reviews Cardiology,
2016; 13(8), 451-470. doi.org/10.1038/nrcardio.2016.76
47. De Vries M. R., Quax P. H. Inflammation in vein graft disease. Frontiers in
cardiovascular medicine, 2018; 5, 3. doi.org/10.3389/fcvm.2018.00003
48. Del Sorbo L. Al-Fares A., Pettenuzzo T. Extracorporeal life support and systemic
inflammation. Intensive care medicine experimental, 2019; 7(1), 1-14.
doi.org/10.1186/s40635-019-0249-y
49. Diegeler A., Doll N., Rauch T., Haberer D., Walther T., Falk V., et al. Humoral
immune response during coronary artery bypass grafting: a comparison of limited
approach, “off-pump” technique, and conventional cardiopulmonary bypass.
Circulation, 2000; 102(suppl_3), Iii-95.68. doi: 10.1161/01.cir.102.suppl_3.iii-95
50. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M. Usefulness of
neopterin levels and left ventricular function for risk assessment in survivors of acute
myocardial infarction. International journal of cardiology, 2006; 111(2), 318-320.
doi.org/10.1016/j.ijcard.2005.11.024
51. Dryer C., Tolpin D., Anton J. Con: mechanical ventilation during cardiopulmonary
bypass does not improve outcomes after cardiac surgery. Journal of Cardiothoracic
and Vascular Anesthesia, 2018; 32(4), 2001-2004.
doi.org/10.1053/j.jvca.2018.02.030
52. Duan H.O., Simpson-Haidaris P.J. Functional analysis of interleukin 6 response
elements (IL-6REs) on the human gammafibrinogen promoter: Binding of hepatic
Stat3 correlates negatively with transactivation potential of type II IL-6REs. J. Biol.
Chem. 2003; 278, 41270–41281. doi.org/10.1074/jbc.M304210200
53. Duran M., Tasbulak O., Alsancak Y. Association between SYNTAX II Score and
late saphenous vein graft failure in patients undergoing isolated coronary artery
bypass graft surgery. Revista da Associação Médica Brasileira, 2021; 67, 1093-1101.
doi.org/10.1590/1806-9282.20210243
54. Erdoes G., Lippuner C., Kocsis I., Schiff M., Stucki M., Carrel T. Technical
approach determines inflammatory response after surgical and transcatheter aortic
143
valve replacement. PloS one, 2015; 10(11), e0143089.
doi.org/10.1371/journal.pone.0143089
55. Erkan K. The role of regulatory T cells in allergic rhinitis and their correlation with
IL-10, IL-17 and neopterin levels in serum and nasal lavage fluid. European Archives
of Oto-Rhino-Laryngology, 2020; 277, 1109-1114. doi.org/10.1007/s00405-020-
05811-4
56. Fan F., Ai Y., Sun T., Li S., Liu H., Shi X. The role of inflammatory cytokines in
anemia and gastrointestinal mucosal injury induced by foot electric stimulation.
Scientific Reports, 2021; 11(1), 1-9. doi.org/10.1038/s41598-021-82604-7
57. Fink M. P., Mythen M. G. The role of gut-derived endotoxin in the pathogenesis of
multiple organ dysfunction. In Endotoxin in health and disease. 2020; 855-864. CRC
Press. doi: 10.1007/BF01704701
58. Gaudino M., Antoniades C., Benedetto U., Deb S., Di Franco A., Di Giammarco. et
al. Mechanisms, consequences, and prevention of coronary graft failure. Circulation,
2017; 136(18), 1749-1764. doi.org/10.1161/CIRCULATIONAHA.117.027597
59. Gokalp O., Yesilkaya N. K., Bozok S., Besir Y., Iner H., Durmaz H. Effects of age
on systemic inflammatory response syndrome and results of coronary bypass surgery.
Cardiovascular Journal of Africa, 2018; 29(1), 22-25. doi: 10.5830/cvja-2018-030
60. Gourlay T., Shedden L. Blood–surface interface in miniaturised extracorporeal
circulation systems. In Minimized Cardiopulmonary Bypass Techniques and
Technologies. Woodhead Publishing. 2012; P-45-61.
doi.org/10.1533/9780857096029.1.45
61. Gu A., Ferraris W. A. Why is MIDCAB the least likely option for coronary
revascularization? The Annals of Thoracic Surgery, 2021; 111(5), 1484-1485.
doi:10.1016/j.athoracsur.2020.07.086
62. Gulielmos Е., Ryan, V. H., Trayhurn, P., Hunter, L., Morris, P. J., German, A. J. 11-
Hydroxy-β-steroid dehydrogenase gene expression in canine adipose tissue and
adipocytes: Stimulation by lipopolysaccharide and tumor necrosis factor α. Domestic
animal endocrinology, 2011; 41(3), 150-161.
doi.org/10.1016/j.domaniend.2011.06.001
144
63. Gupta S., Varol, E., Gülcan, M., Aylak, F., Özaydın, M., Sütçü, R. et al. Increased
neopterin levels and its association with angiographic variables in patients with slow
coronary flow: an observational study. Anatolian Journal of Cardiology/Anadolu
Kardiyoloji Dergisi, 2011; 11(8). doi:10.5152/akd.2011.190
64. Halabi A.R., Alexander J.H., Shaw L.K., Lo-renz T.J., Liao L., Kong D.F. et al.
Relation of early saphenous vein graft failure to outcomes followingcoronary artery
bypass surgery. Am. J. Cardiol. 2005; 96:1254–7. doi: 10.1016/j.amj-
card.2005.06.067
65. Ham O., Lee S.Y., Song B.W., Lee C.Y., Lee J., Seo H.H. et al. Small molecule-
mediated induction of miR-9 suppressed vascular smooth muscle cell proliferation
and neointima formation after balloon injury. Oncotarget. 2017; 8 (55): 93360–72.
doi: 10.18632/oncotarget.21382
66. Hanna A., Frangogiannis N. G. Inflammatory cytokines and chemokines as
therapeutic targets in heart failure. Cardiovascular Drugs and Therapy, 2020; 34(6),
849-863. doi.org/10.1007/s10557-020-07071-0
67. Harskamp R.E., Alexander J.H., Schulte P.J., Brophy C.M., Mack M.J., Peterson
E.D. Vein graft preservation solutions, patency, and outcomes after coronary artery
bypass graft surgery: follow-up from the PREVENT IV randomized clinical trial.
JAMA Surg. 2014; 149 (8): 798–805. doi: 10.1001/jama.294.19.2446
68. Harskamp R.E., Lopes R.D., Baisden C.E., deWinter R.J., Alexander J.H.
Saphenous vein graft failure after coronary artery bypass surgery: patho-physiology,
management, and future directions.Ann. Surg. 2013; 257: 824–9. doi:
10.1097/SLA.0b013e318288c38d
69. Hayashi, S. I., Rakugi, H., Morishita, R. Insight into the role of angiopoietins in
ageing-associated diseases. Cells, 2020; 9(12), 2636. doi.org/10.3390/cells9122636
70. Heeschen C., Dimmeler S., Fichtlscherer S., Hamm CW., Berger J., Simoons ML. et
al. CAPTURE Investigators. Prognostic value of placental growth factor in patients
with acute chest pain. J Am Med Assoc 2004; 291:435—41.
doi:10.1001/jama.291.4.435
145
71. Heesterbeek D. A., Angelier M. L., Harrison R. A., Rooijakkers S. H. Complement
and bacterial infections: from molecular mechanisms to therapeutic applications.
Journal of Innate Immunity, 2018; 10(5-6), 455-464. doi.org/10.1159/000491439
72. Held C., White H.D., Stewart R.A., Budaj A., Cannon C.P, Hochman J.S., et al.
Inflammatory Biomarkers Interleukin-6 and C-Reactive Protein and Outcomes in
Stable Coronary Heart Disease: Experiences from the STABILITY (Stabilization of
Atherosclerotic Plaque by Initiation of Darapladib Therapy) Trial. J. Am. Heart
Assoc. 2017; 6, e005077. doi.org/10.1161/JAHA.116.005077
73. Heo R. H., Wang M. K., Meyre P. B., Birchenough L., Park L., Vuong K., Conen D.
Associations of inflammatory biomarkers with the risk of morbidity and mortality
after cardiac surgery: a systematic review and meta-analysis. Canadian Journal of
Cardiology. 2023; 1, 124-137. doi.org/10.1016/j.cjca.2023.07.021
74. Hess C.N., Lopes R.D., Gibson C.M., Hager R., Wojdyla D.M., Englum B.R. et al.
Saphenous vein graft failure after coronary artery bypass surgery: insights from
PREVENT-IV. Circulation. 2014; 130 (17): 1445–6.
doi:10.1161/circulationaha.113.008193
75. Hesse D. G., Shih H. J., Chang C. Y., Chiang M., Le V. L., Hsu H. J. et al.
Simultaneous inhibition of three major cytokines and its therapeutic effects: a
peptide-based novel therapy against endotoxemia in mice. Journal of Personalized
Medicine, 2021; 11(5), 436. doi.org/10.3390/jpm11050436
76. Hurley J. C., Nowak P., Öhrmalm L., Gogos C., Armaganidis A., Giamarellos A. et
al. Endotoxemia as a diagnostic tool for patients with suspected bacteremia caused by
gram-negative organisms: a meta-analysis of 4 decades of studies. Journal of Clinical
Microbiology, 2015; 53(4), 1183-1191. doi.org/10.1128/JCM.03531-14
77. Husberg C., Nygård S., Finsen A. V., Damås J. K., Frigessi A., Øie E., Christensen
G. Cytokine expression profiling of the myocardium reveals a role for CX3CL1
(fractalkine) in heart failure. Journal of molecular and cellular cardiology, 2008;
45(2), 261-269. doi.org/10.1016/j.yjmcc.2008.05.009
146
78. Ji C.L, Nomi A., Li B. Increased Plasma Soluble Fractalkine in Patients with
Chronic Heart Failure and Its Clinical Significance. Int Heart J 2019; 60 (3): 701-7.
doi:10.1536/ihj.18-422
79. Jia R. F., Li L., Li H., Cao X. J., Ruan Y., Meng S. et al. Meta-analysis of C-reactive
protein and risk of angina pectoris. The American Journal of Cardiology, 2020;
125(7), 1039-1045. doi.org/10.1016/j.amjcard.2020.01.005
80. John B. Steinberg, Aljure O. D., Fabbro M. Cardiopulmonary bypass and
inflammation: the hidden enemy. Journal of cardiothoracic and vascular anesthesia,
2019; 33(2), 346-347. doi.org/10.1053/j.jvca.2018.05.030
81. Johnston D., Gagos M., Raio N., Ragolia L., Shenouda D., Davis-Lorton M., De
Leon J. R. Alterations in serum neopterin correlate with thrombolysis in myocardial
infarction risk scores in acute coronary syndromes. Coronary artery disease, 2006;
17(6), 511-516.
82. Jongman R. M., Zijlstra J. G., Kok W. F., van Harten A. E., Mariani M. A., Moser J.
et al. Off-pump CABG surgery reduces systemic inflammation compared with on-
pump surgery but does not change systemic endothelial responses: a prospective
randomized study. Shock, 2014; 42(2), 121-128. doi:
10.1097/SHK.0000000000000190
83. Kockx M.M., DeMeyer G.R.Y., Bortier H., deMeyere N., Muhring J., Bakker A. et
al. Luminal foam cell accumulation is associated with smooth muscle cell death in
the intimal thickening of human saphenous vein grafts. Circulation. 2006; 94: 1255–
62. doi: 10.1161/01.cir.94.6.1255
84. Kosmidou I., Redfors B., Chen S., Crowley A., Lembo N. J., Karmpaliotis D. et al.
C-reactive protein and prognosis after percutaneous coronary intervention and bypass
graft surgery for left main coronary artery disease: analysis from the EXCEL trial.
American heart journal, 2019; 210, 49-57. doi.org/10.1016/j.ahj.2018.12.013
85. Knuuti J., Wijns W., Saraste A. 2019 ESC guidelines on the diagnosis and
management of chronic coronary syndromes: the task force for diagnosis and
management of chronic coronary syndromes of the European society of cardiology
(ESC) Eur Heart J. 2020; 41:407–477. doi: 10.1093/eurheartj/ehz425
147
86. Kraler S., Libby P., Evans P.C., Akhmedov A., Schmiady M.O., Reinehr M.
Resilience of the internal mammary artery to atherogenesis: shifting from risk to
resistance to address unmet needs. Arterioscl. Thromb. Vasc. Biol. 2021; 41: 2237–
51. doi: 10.1161/ATVBAHA.121.316256
87. Landis R.C., Haskard D.O., Taylor K.M. New antiinflammatory and platelet-
preserving effects of aprotinin. Ann Thorac Surg 2001; 72: S1808-S1813 doi:
10.1016/s0003-4975(01)03193-9
88. Lawrence S.M., Corriden R., Nizet V. The ontogeny of a neutrophil: mechanisms of
granulopoiesis and homeostasis //Microbiology and Molecular Biology Reviews.
2018; Т. 82. – №. 1. – С. e00057-17. doi.org/10.1128/MMBR.00057-17
89. Lee G. S., Kang T. J. Cuttlebone Shows Anti-inflammatory Activity Via Suppression
of NF-κB Activation in LPS-induced RAW 264.7 Macrophages //Yakhak Hoeji.
2021; Т. 65. – №. 1. – С. 41-45. doi.org/10.17480/psk.2021.65.1.41
90. Li C., Zhong X., Xia W., He J., Gan H., Zhao H., et al. The CX3CL1/CX3CR1 axis
is upregulated in chronic kidney disease and contributes to angiotensin II-induced
migration of vascular smooth muscle cells. Microvascular Research, 2020; 132,
104037. doi.org/10.1016/j.mvr.2020.104037
91. Li H., Sun K., Zhao R., Hu J., Hao Z., Wang F. et al. Inflammatory biomarkers of
coronary heart disease. Frontiers in Bioscience-Scholar, 2018; 10(1), 185-196. doi:
10.2741/s508
92. Li J., Richter B., Koller L., Hohensinner P. J., Rychli K., Zorn G., Goliasch G. et al.
Fractalkine is an independent predictor of mortality in patients with advanced heart
failure. Thrombosis and haemostasis, 2012; 108(12), 1220-1227. doi: 10.1160/TH12-
03-0195
93. Li J., Guo Y., Luan X., Qi T., Li D., Chen Y., Chen W. Independent roles of
monocyte chemoattractant protein-1, regulated on activation, normal T-cell expressed
and secreted and fractalkine in the vulnerability of coronary atherosclerotic plaques.
Circulation Journal, 2012; 76(9), 2167-2173. doi.org/10.1253/circj. CJ-11-1457
148
94. Liu H., Jiang D., Zhang S., Ou B. Aspirin inhibits fractalkine expression in
atherosclerotic plaques and reduces atherosclerosis in ApoE gene knockout mice.
Cardiovasc Drugs Ther 2010; 24: 17-24. doi.org/10.1007/s10557-009-6210-7
95. Liu P., Shahzad K. A., Qin Z., Li Y., Xia D. The roles of focal adhesion and
cytoskeleton systems in fluid shear stress-induced endothelial cell response. Biocell,
2020; 44(2), 137. doi: 10.32604/biocell.2020.08500
96. Libby P. Interleukin-1 beta as a target for atherosclerosis therapy: biological basis of
CANTOS and beyond. Journal of the American College of Cardiology, 2017; 70(18),
2278-2289. doi: 10.1016/j.jacc.2017.09.028
97. Liuzzo G., Biasucci L.M., Gallimore J.R., Grillo R.L., Rebuzzi A.G., Pepys M.B.
et.al. The prognostic value of C-reactive protein and serum amyloid a protein in
severe unstable angina. N Engl J Med. 1994 Aug 18;331(7):417-24. doi:
10.1056/NEJM199408183310701
98. Lopes R.D., Mehta R.H., Hafley G.E., Wil-liams J.B., Mack M.J., Peterson
E.D. et al. Relationship between vein graft failure and subse-quent clinical outcomes
after coronary artery bypass surgery. Circulation. 2012; 125: 749–7.
doi:10.1161/CIRCULATIONAHA.111.040311
99. Lucas A., Bursill T., Guzik J., Sadowski K., Channon А., Greaves D. “Smooth
Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor
CX3CR1 and Undergo Chemotaxis to the CX3C Chemokine Fractalkine (CX3CL1).
2003;” Circulation 108 (20): 2498–2504.
doi.org/10.1161/01.CIR.0000097119.57756.EF
100. Mach L., Bedanova H., Soucek M., Karpisek M., Konecny T., Nemec P. Impact
of cardiopulmonary bypass surgery on cytokines in epicardial adipose tissue:
comparison with subcutaneous fat. Perfusion, 2017; 32(4), 279-284.
doi.org/10.3389/fnagi.2021.699763
101. Mallat Z., Corbaz A., Scoazec A. Expression of interleukin-18 in human
atherosclerotic plaques and relation to plaque instability. Circulation. 2001;
104:1598–1603 doi.org/10.1161/hc3901.096721
149
102. Marcano A. L., Lugo L. M., Besteiro A., Gomez-Lara J., Roura G., Fuentes L. et
al. Association of fractalkine with functional severity of heart failure and impact on
clopidogrel efficacy in patients with ischemic heart disease. Thrombosis Research,
2020; 196, 215-221. doi.org/10.1016/j.thromres.2020.08.041
103. Maruhashi T., Kihara Y., Higashi Y. Assessment of endothelium-independent
vasodilation: from methodology to clinical perspectives. Journal of hypertension,
2018; 36(7), 1460-1467. doi: 10.1097/HJH.0000000000001750
104. Matata B.M., Martin J., Cheng D. C., Benussi S., Bonatti J. O., Diegeler A. et al.
ISMICS consensus conference and statements of randomized controlled trials of off-
pump versus conventional coronary artery bypass surgery. Innovations, 2015; 10(4),
219-229. doi.org/10.1097/imi.0000000000000184
105. Mehta R.H., Ferguson T.B., Lopes R.D., Hafley G.E., Mack M.J., Kouchoukos
N.T. et al. Saphenous vein grafts with multiple versus single distal targets in patients
undergoing coronary artery bypass surgery: one-year graft failure and five-year
outcomes from the project of ex-vivo vein graftengineering via transfection
(PREVENT) IV trial. Circulation. 2011; 124: 280–8. doi: 10.1161/CIR-
CULATIONAHA.110.991299
106. Moller C.H, Steinbruchel D.A. Platelet function after coronary artery bypass
grafting: Is there a procoagulant activity after off-pump compared with on-pump
surgery? Scand Cardiovasc J 2003; 37:149-153. doi: 10.1080/14017430310001456
107. Mujalli A., Banaganapalli B., Alrayes N. M., Shaik N. A., Elango R., Al-Aama J.
Y. Myocardial infarction biomarker discovery with integrated gene expression,
pathways and biological networks analysis. Genomics, 2020; 112(6), 5072-5085.
doi.org/10.1016/j.ygeno.2020.09.004
108. Naka K.K., Papathanassiou K., Bechlioulis A., Pappas K., Tigas S., Makriyiannis
D. Association of vascular indices with novel circulating biomarkers as prognostic
factors for cardiovascular complications in patients with type 2 diabetes mellitus.
Clinical biochemistry, 2018; 53, 31-37. doi.org/10.1016/j.clinbiochem.2017.12.010
109. Neurauter G., Wirleitner B., Laich A., Schennach H., Weiss G., Fuchs D.
Atorvastatin suppresses interferon-γ-induced neopterin formation and tryptophan
150
degradation in human peripheral blood mononuclear cells and in monocytic cell lines.
Clinical Experimental Immunology, 2003; 131(2), 264-267. doi.org/10.1046/j.1365-
2249.2003.02021.
110. Nowicki M., Perek B. Histological analysis in graft disease. In: Coronary graft
failure. Springer, Cham; 2016; 219–25. doi: 10.1007/978-3-319-26515-5_21.
111. Ołdakowska M., Ściskalska M., Kepinska M., Marek G., Milnerowicz H.
Association of Genetic Variants in IL6 Gene (rs1800795) with the Concentration of
Inflammatory Markers (IL-6, hs-CRP) and Superoxide Dismutase in the Blood of
Patients with Acute Pancreatitis—Preliminary Findings. Genes, 2022; 13(2), 290.
doi.org/10.3390/genes13020290
112. Onorati F., Santarpino G., Rubino A.S., Caroleo S., Dardano A., Scalas C. et al.
Body perfusion during adult cardiopulmonary bypass is improved by pulsatile flow
with intra-aortic balloon pump. Int J Artif Organs 2009; 32(January):50—61. doi:
10.1177/039139880903200107
113. Okubo Е., Mach L., Bedanova H., Soucek M., Karpisek M., Konecny T. et al.
Impact of cardiopulmonary bypass surgery on cytokines in epicardial adipose tissue:
comparison with subcutaneous fat. Perfusion, 2017; 32(4), 279-284.
doi.org/10.1177/0267659116683791
114. Parolari A., Camera M., Alamanni F., Naliato M., Polvani G.L., Agrifoglio M. et
al. Systemic Inflammation After On-Pump and Off-Pump Coronary Bypass Surgery:
A One-Month Follow-Up. Ann. Thorac. Surg. 2007; 84: 823 - 828.
doi.org/10.1016/j.athoracsur.2007.04.048
115. Passov S., Petäjä D., Pihlajoki L., Salminen M., Suojaranta U. The origin of
plasma neutrophil gelatinase-associated lipocalin in cardiac surgery. BMC
nephrology, 2019; 20(1), 1-10. doi: 10.1186/s12882-019-1380-4
116. Plicner D., Stoliński J., Wąsowicz M., Gawęda B., Hymczak H., Kapelak B. et al.
Preoperative values of inflammatory markers predict clinical outcomes in patients
after CABG, regardless of the use of cardiopulmonary bypass. Indian heart journal,
2016; 68, S10-S15. doi.org/10.1016/j.ihj.2016.10.002
Соседние файлы в папке Библиотека им академика М.И. Перельмана